abstract |
The present invention relates to a solid form of N-((S) -2,3-dihydroxy-propyl) -3- (2-fluoro-4-iodo-phenylamino) -isonicotinamide, or a pharmaceutically acceptable salt thereof It relates to a salt, a process for its preparation, for example formula (I), and its medical use. |